VYCO News Alert Vycor Medical Inc. (VYCO) 1.8000 12/17/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vycor Medical Inc. (VYCO) 1.8000 $VYCO

Vycor Announces Commercial Launch of NeuroEyeCoach(TM) Professional Physician Edition
ACCESSWIRE - Mon Nov 24, 7:00AM CST
BOCA RATON, FL / ACCESSWIRE / November 24, 2014 / Vycor Medical, Inc. ("Vycor" (OTCQB-VYCO), a provider of innovative and superior surgical and therapeutic solutions, announced that its wholly owned subsidiary NovaVision, Inc. had successfully completed the development of and was in the process of commercially launching its NeuroEyeCoach(TM) Professional Physician Edition. The launch of this Edition was the result of demand from physicians who wanted to be able to initiate patients on the NeuroEyeCoach(TM) program in their office or clinic and then have patients continue the program at home, supported by NovaVision staff, while being able to monitor the patient's progress through a dedicated portal access point.

Vycor Medical to Present at the LD Micro Conference on December 3
ACCESSWIRE - Tue Nov 18, 7:00AM CST
BOCA RATON, FL/ ACCESSWIRE / November 18, 2014 / Vycor Medical, Inc. ("Vycor" (OTCQB-VYCO), a provider of innovative and superior surgical and therapeutic solutions, is pleased to announce that Peter Zachariou, Chief Executive Officer and David Cantor, President, will present at the LD MICRO Conference at 9:30 a.m. (PT), Track 3, on Wednesday, December 3, 2014. The conference will be held December 2-4, 2014 at the Luxe Sunset Boulevard Hotel, 11461 Sunset Boulevard, Los Angeles, CA. The Company's group presentation will be available for the public to access at http://wsw.com/webcast/ldmicro7/vyco. This webcast will be archived for 90 days following the live presentation. Vycor Medical management will be available during the day on December 3 for one-on-one meetings. Please contact LD MICRO to schedule a meeting.

Vycor Medical Releases Financial Results for Third Quarter and First Nine Months of 2014
ACCESSWIRE - Wed Nov 12, 12:00PM CST
Vycor VBAS up 41% for first nine months over same period in 2013 Non-GAAP Net Operating Loss reduced by 12%

VYCOR: "On the Cusp of the Next Big Healthcare Trend"
ACCESSWIRE - Mon Nov 10, 8:23AM CST
Vycor: "On the Cusp of the Next Big Healthcare Trend"
MDVN: 102.50 (-1.58), ABMD: 35.85 (-0.40), JNJ: 102.76 (-1.20), AMGN: 159.44 (-0.16), EXAS: 25.14 (-1.80), ARAY: 6.59 (-0.05), HOLX: 25.64 (+0.05), PBYI: 195.44 (+0.11)

Leading Neurosurgeon to Present at Vycor's Booth at Congress of Neurological Surgeons in Boston
Marketwired - Thu Oct 16, 7:31AM CDT
Vycor Medical, Inc. ("Vycor" (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, is pleased to announce that Dr. Antonio Bernardo, from the Department of Neurological Surgery at Weill Cornell Medical College, will present and field questions on his recent work on minimally invasive neurosurgical approaches through Vycor Medical's ViewSite(TM) Brain Access System (VBAS) at the 2014 meeting of the Congress of Neurological Surgeons in Boston, Massachusetts. Dr. Bernardo will demonstrate the novel techniques developed in his laboratory that may mitigate the risk of postoperative seizures, aphasia, and venous complications through minimization of brain retraction in the middle fossa approach and other selected skull base procedures while improving cosmetic outcomes. Additionally, by limiting the range of instrument movement and protecting the surrounding tissues from instruments within the working channel, the tubular retractor may reduce inadvertent iatrogenic instrumental injury and thermal injury from the endoscope light or electrocautery.

Vycor Continues to Execute on Its Stated Strategic Goal of Expanding Internationally
Marketwired - Mon Oct 13, 7:01AM CDT
Vycor Medical, Inc. ("Vycor" (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, announced that it had made significant in-roads into a number of key international markets. Most recently it has entered into a distribution agreement with Eurotech, a leading Russian distributor of surgical devices, and secured its first order. In addition to Russia, Vycor has identified and started to work with neurosurgical distributors in the following markets: Brazil, France, South Africa, Sri Lanka and Taiwan. In each of these markets, Vycor has entered into either evaluation or distribution agreements and is now going through local regulatory approvals. Including these countries, Vycor now has international agreements in place for VBAS in Australia, Belgium, Brazil, Canada, China, France, Germany, Greece, Holland, Hong Kong, Italy, Japan, Korea, Russia, South Africa, Spain, Sri Lanka, Sweden, Taiwan and the UK.

Prominent Researchers to Present Minimally Invasive Surgeries Utilizing Vycor Medical's VBAS at Congress of Neurosurgery
Marketwired - Fri Oct 10, 7:30AM CDT
Vycor Medical, Inc. ("Vycor" (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, is pleased to announce that researchers from the Department of Neurological Surgery at Weill Cornell Medical College will present their recent work on minimally invasive neurosurgical approaches through Vycor Medical's ViewSite(TM) Brain Access System (VBAS) at the 15th European Congress of Neurosurgery in Prague. Prof. Antonio Bernardo, Director of the Surgical Innovations Lab for Skull Base and Microneurosurgery at Weill Cornell, will deliver a presentation on minimally invasive supraorbital and middle fossa approaches to intracranial targets on Tuesday, October 14th at 15:30 in Hall E.

Weill Cornell Neurosurgeons to Present Procedures Carried Out Using Vycor's VBAS at International Congress on Minimally Invasive Techniques in Neurosurgery
Marketwire - Thu Sep 04, 7:36AM CDT
Vycor Medical, Inc. ("Vycor" (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, announced that researchers from the Department of Neurological Surgery at Weill Cornell Medical College will present their recent work on minimally invasive neurosurgical approaches using Vycor Medical's ViewSite(TM) patented Brain Access System (VBAS) next week, from September 11 to 13, at the 2nd International Congress on Minimally Invasive Techniques in Neurosurgery in Xian, China. Members of the research team will meet with surgeons before the conference to demonstrate novel techniques that may help diminish the risk of retraction injury while surgically accessing the third ventricle and which may mitigate the risk of post-operative seizures, aphasia, and venous complications through minimization of brain retraction in the middle fossa approach while improving cosmetic outcomes. The team will also provide an in-depth technical demonstration of these techniques to local surgeons.

Vycor Reports 41% Year-to-Date Revenue Growth
Marketwire - Tue Aug 12, 7:31AM CDT
Vycor Medical, Inc. ("Vycor" (OTCQB: VYCO), today announced financial results for the second quarter and first six months of 2014.

New Image Guided VBAS Prototype Work Completed
Marketwire - Thu Aug 07, 7:00AM CDT
Vycor Medical, Inc. ("Vycor" (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, announced that it had successfully completed the development of new prototypes of its patented ViewSite(TM) Brain Access System ("VBAS" device that will be fully compatible with selected image-guided systems. The device has been specifically designed to house the pointer utilized in image-guided systems. The pointer will be firmly held in place in the introducer through a novel approach while the working channel will remain unchanged. The Company will now commence the testing of these devices. Initially the Company plans on manufacturing four new devices targeted at this market, this development being spurred by strong neurosurgeon demand. VBAS is currently approved in over 170 hospitals in the U.S. and more than 6,500 surgeries have been performed worldwide utilizing VBAS.

Vycor Medical Boosts Shareholder Equity by $2.4 million
Marketwire - Tue Aug 05, 7:31AM CDT
Vycor Medical, Inc. ("Vycor" or the "Company" (OTCQB: VYCO), today announces that its largest shareholder, Fountainhead Capital Management Limited ("Fountainhead" , along with certain other related and non-related parties (together, the "Fountainhead Parties" , has agreed to exchange all of its $2,355,587 of debt into an equivalent amount of preferred equity in the company.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 140

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 203

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 71

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 95

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 126

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 180

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 78

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 139

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 116

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 172

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading

Top 5 Most Recently Viewed Articles

Bitcoin Faces Criticism While BlackRock Sees Financial Success

Updated Category News Views 167

Bitcoin Under Scrutiny In recent discussions, Peter Schiff has taken to social media to share his critical views on Bitcoin, branding it as a "fake asset." His assertion comes after Bitcoin's price retracement from its historic highs, indicating a significant downturn. Currently, Bitcoin is trading at around $81,000 after once peaking at $110,000. Schiff argues that the...

Continue Reading
Valneva Secures $32.8 Million Contract for IXIARO Vaccine Supply

Updated Category News Views 213

Valneva Expands IXIARO Vaccine Supply with New Contract Valneva SE, a leading specialized vaccine company, has officially announced a significant step forward in its partnership with the U.S. Department of Defense (DoD) by signing a new contract valued at a minimum of $32.8 million for the IXIARO vaccine. This substantial agreement marks another chapter in Valneva's...

Continue Reading
EFGH and Minerva Forge Strategic Partnership for Data Centres

Updated Category News Views 118

EFGH and Minerva Unite to Enhance Ghana's Digital Landscape In a landmark agreement, Embed Financial Group Holdings (EFGH) has joined forces with Minerva Data Limited, a prominent player in digital infrastructure, to create advanced data centres and strengthen the technology ecosystem in Ghana. This collaboration marks a significant step in addressing the growing demand...

Continue Reading
Landsea Homes Achieves Remarkable Growth in Q3 Results

Updated Category News Views 50

Strong Financial Performance in Q3 Landsea Homes Corporation (NASDAQ: LSEA) reported impressive financial results for the third quarter, demonstrating robust performance in the residential homebuilding sector. For the quarter, Landsea Homes achieved a net income of $11.1 million, translating to $0.30 per share. This marks a 29% increase in net income compared to the...

Continue Reading
Urban Logistics REIT: Key Disclosure Insights for Investors

Updated Category News Views 219

Understanding the Disclosure from Urban Logistics REIT In the realm of public trading, disclosures play a pivotal role in keeping investors informed about changes in significant stakes within companies. Recently, Urban Logistics REIT Plc, underlining its commitment to transparency, provided valuable insights through its disclosure concerning investor positions, managed by...

Continue Reading